Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies

  • Scott, Jamie I.
  • Mendive Tapia, Lorena
  • Gordon, Doireann
  • Barth, Nicole D.
  • Thompson, Emily J.
  • Cheng, Zhiming
  • Taggart, David
  • Kitamura, Takanori
  • Bravo-Blas, Alberto
  • Roberts, Edward W.
  • Juárez Jiménez, Jordi
  • Michel, Julien
  • Piet, Berber
  • Vries, I. Jolanda de
  • Verdoes, Martijn
  • Dawson, John
  • Carragher, Neil
  • O' Connor, Richard A.
  • Akram, Ahsan R.
  • Frame, Margaret
  • Serrels, Alan
  • Vendrell, Marc
Immunotherapy promotes the attack of cancer cells by the immune system; however, it is difficult to detect early responses before changes in tumor size occur. Here, we report the rational design of a fluorogenic peptide able to detect picomolar concentrations of active granzyme B as a biomarker of immune-mediated anticancer action. Through a series of chemical iterations and molecular dynamics simulations, we synthesize a library of FRET peptides and identify probe H5 with an optimal fit into granzyme B. We demonstrate that probe H5 enables the real-time detection of T cell-mediated anticancer activity in mouse tumors and in tumors from lung cancer patients. Furthermore, we show image-based phenotypic screens, which reveal that the AKT kinase inhibitor AZD5363 shows immune-mediated anticancer activity. The reactivity of probe H5 may enable the monitoring of early responses to anticancer treatments using tissue biopsies.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Fluorogenic Granzyme A substrates enable real-time imaging of adaptive immune cell activity

  • Cheng, Zhiming
  • Thompson, Emily J.
  • Mendive-Tapia, Lorena
  • Scott, Jamie I.
  • Benson, Sam
  • Kitamura, Takanori
  • Senán Salinas, Ana
  • Samarakoon, Youhani
  • Roberts, Edward W.
  • Arias, Maykel
  • Pardo, Julián
  • Gálvez Buerba, Eva Mª
6 figures., Cytotoxic immune cells, including T lymphocytes (CTLs) and natural killer (NK) cells, are essential components of the host response against tumors. CTLs and NK cells secrete granzyme A (GzmA) upon recognition of cancer cells; however, there are very few tools that can detect physiological levels of active GzmA with high spatiotemporal resolution. Herein, we report the rational design of the near-infrared fluorogenic substrates for human GzmA and mouse GzmA. These activity-based probes display very high catalytic efficiency and selectivity over other granzymes, as shown in tissue lysates from wild-type and GzmA knock-out mice. Furthermore, we demonstrate that the probes can image how adaptive immune cells respond to antigen-driven recognition of cancer cells in real time., A. S. acknowledges a PhD fellowship from the Aragon Government. M. A. A. acknowledges funds from the Ministry of Economy and Competitiveness, Spain (IJC2019- 039192-I). This research was supported by CIBER (CB 2021), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea-NextGenerationEU, FEDER (Group B29_20R), Ministry of Science, Innovation and Universities and Agencia Estatal de Investigación, Spain (SAF2017-83120-C2-1-R and PID2020-113963RB-I00). T. K. acknowledges funding from an MRC Career Development Award (MR/S006982/1) and an MRC Centre Grant (MR/N022556/1). E. W. R. acknowledges a Cancer Research UK grant (A_BICR_1920_Roberts). M. V. acknowledges funds from an ERC Consolidator Grant (DYNAFLUORS, 771443) and an ERC PoC Grant (IBDIMAGE, 957535). This project has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement (859908)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies

  • Scott, Jamie I.
  • Mendive Tapia, Lorena
  • Gordon, Doireann
  • Barth, Nicole D.
  • Thompson, Emily J.
  • Cheng, Zhiming
  • Taggart, David
  • Kitamura, Takanori
  • Bravo-Blas, Alberto
  • Roberts, Edward W.
  • Juárez Jiménez, Jordi
  • Michel, Julien
  • Piet, Berber
  • Vries, I. Jolanda de
  • Verdoes, Martijn
  • Dawson, John
  • Carragher, Neil
  • O' Connor, Richard A.
  • Akram, Ahsan R.
  • Frame, Margaret
  • Serrels, Alan
  • Vendrell, Marc
Immunotherapy promotes the attack of cancer cells by the immune system; however, it is difficult to detect early responses before changes in tumor size occur. Here, we report the rational design of a fluorogenic peptide able to detect picomolar concentrations of active granzyme B as a biomarker of immune-mediated anticancer action. Through a series of chemical iterations and molecular dynamics simulations, we synthesize a library of FRET peptides and identify probe H5 with an optimal fit into granzyme B. We demonstrate that probe H5 enables the real-time detection of T cell-mediated anticancer activity in mouse tumors and in tumors from lung cancer patients. Furthermore, we show image-based phenotypic screens, which reveal that the AKT kinase inhibitor AZD5363 shows immune-mediated anticancer activity. The reactivity of probe H5 may enable the monitoring of early responses to anticancer treatments using tissue biopsies.